Category: Biospecimen News
Scientists can guess your age from your microbes
March 12, 2020
Microorganisms on and in your body can tell scientists your age – sometimes within four years– setting the stage for new interventions and diagnostic tools built on analyses of microbes in your mouth, on your skin, and in your fecal matter.
Experimental liquid biopsy predicts gastric cancer recurrence
March 5, 2020
A blood draw has successfully predicted the recurrence of gastric cancer long before it would otherwise be detectible in the latest example of liquid biopsy’s promise.
CRISPR-Edited Stem Cells Yield Impressive Early Results
December 12, 2019
Two patients with serious conditions have shown remarkable results after receiving cutting-edge treatment using CRISPR, the revolutionary gene-editing tool, to alter blood-producing stem cells.
Specimens Drive Discovery in Kidney Disease Testing
December 4, 2019
Using data from the records of more than 400,000 patients in the UK Biobank, researchers from the University of Glasgow say they’ve been able to determine which of three kidney function tests is the most effective at predicting cardiovascular risk, which is associated with chronic kidney disease.
Transforming human biospecimen procurement to help advance R&D and change lives
June 13, 2019
Although biobanks around the world have since amassed millions of human biospecimens, and valuable insights have been extracted from them, the biospecimen procurement challenge is holding firm. Recently, iSpecimen launched a survey of its own, recasting several questions similar to those included in the aforementioned OBBR survey, to take a pulse on potential improvements related to the availability of quality specimens.
Human biospecimens + AI = new insights
April 11, 2019
Every human biospecimen contains a wealth of data – about patients, their conditions and the biological processes that the sample has undergone. Data is also the currency of artificial intelligence, which is streamlining discovery by crunching data as biospecimens are presented to computers.
A blood test could take the guesswork out of pain
February 21, 2019
In a development that could someday help address the opioid scourge, University of Indiana School of Medicine researchers say they have developed a prototype blood test that quantifies pain based on molecular biomarkers.
New biospecimens, critical to important research, available on iSpecimen Marketplace
January 24, 2019
Now our customers can receive primary cells from bone marrow and peripheral blood that are shipped within hours of collection They are the cells that spawn our oxygen-carrying red blood cells, disease-fighting white blood cells and clot-forming platelets. They are found in the bone marrow and, in smaller numbers, in the circulating blood. They are […]
As Specimens Lie Idle in Freezers, Patients Await Cures
May 22, 2018
And biobanks lose needed revenue Although biobanks do tremendous good for the world, many want to do even better. Biobanks collect tissue, biofluids and cells for use by researchers working toward new cures, treatments and vaccines. To better understand their challenges, we created a detailed questionnaire that 42 biobank professionals from around the world filled […]
Catching Up with Chris Ianelli, Founder and CEO of iSpecimen
September 21, 2017
Our CEO, Chris Ianelli, MD, PhD, was recently interviewed by Precision Medicine World Conference (PMWC), where he will be speaking in January 2018, about the power of the iSpecimen Marketplace in redefining the way human biospecimens are procured. PMWC attracts recognized authorities and experts across healthcare and biotechnology sectors, and we are very excited for […]
Previous |
- © 2020 iSpecimen, Inc.
- All rights reserved.
